ConductScience.org, home

Paper20028824

Elucidation of the pharmacokinetic/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection models.

Dudhani RV and 6 others. Antimicrob Agents Chemother, 2010. Cited by 161 papers, by iCite.

Cite this record

ConductScience Library. Elucidation of the pharmacokinetic/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection models. Papers, record 20028824. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20028824

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Elucidation of the pharmacokinetic/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection models.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
161
iCite
Relative citation ratio, by iCite
5.89
iCite
Revised in PubMed
2025-05-29
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dudhani RVRajesh V
2Turnidge JDJohn D
3Coulthard KKingsley
4Milne RWRobert W
5Rayner CRCraig R
6Li JJian
7Nation RLRoger L

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
ColistinMajor topic
Disease Models, AnimalMajor topic
Lung DiseasesMajor topic
Pseudomonas InfectionsMajor topic
Pseudomonas aeruginosaMajor topic
ThighMajor topic
Animals
Area Under Curve
Female
Humans
Lung
Mice
Microbial Sensitivity Tests
Neutropenia
Specific Pathogen-Free Organisms

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AI070896NIAID NIH HHSUnited StatesR01AI070896PubMed and NIHNIH RePORTER
R01 AI079330NIAID NIH HHSUnited StatesR01AI079330PubMed and NIHNIH RePORTER
R01AI079330NIAID NIH HHSUnited StatesR01AI079330PubMed and NIHNIH RePORTER
R01AI070896NIAID NIH HHSUnited StatesR01AI070896PubMed and NIHNIH RePORTER

Download CSV of grants

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117182346Anti-infective research and development--problems, challenges, and solutions.Lancet Infect Dis2007https://conductscience.org/library/papers/17182346PubMed
216931410Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections.Lancet Infect Dis2006https://conductscience.org/library/papers/16931410PubMed
38161713Dose-dependent pharmacokinetics: experimental observations and theoretical considerations.Biopharm Drug Dispos1994https://conductscience.org/library/papers/8161713PubMed
411587346
A simple method for the assay of colistin in human plasma, using pre-column derivatization with 9-fluorenylmethyl chloroformate in solid-phase extraction cartridges and reversed-phase high-performance liquid chromatography.
J Chromatogr B Biomed Sci Appl2001https://conductscience.org/library/papers/11587346PubMed
518343250
Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study.
Clin Ther2008https://conductscience.org/library/papers/18343250PubMed
66842025Impact of dosing intervals on activity of gentamicin and ticarcillin against Pseudomonas aeruginosa in granulocytopenic mice.J Infect Dis1983https://conductscience.org/library/papers/6842025PubMed
718180359Subacute toxicity of colistin methanesulfonate in rats: comparison of various intravenous dosage regimens.Antimicrob Agents Chemother2008https://conductscience.org/library/papers/18180359PubMed
87624896Changes in the serum protein binding of vancomycin in patients with methicillin-resistant Staphylococcus aureus infection: the role of serum alpha 1-acid glycoprotein levels.Ther Drug Monit1995https://conductscience.org/library/papers/7624896PubMed
918227094Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model.J Antimicrob Chemother2008https://conductscience.org/library/papers/18227094PubMed
10180874Significance of serum protein and tissue binding of antimicrobial agents.Annu Rev Med1976https://conductscience.org/library/papers/180874PubMed
1118358794Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients.J Cyst Fibros2008https://conductscience.org/library/papers/18358794PubMed
1217159923Drugs for bad bugs: confronting the challenges of antibacterial discovery.Nat Rev Drug Discov2007https://conductscience.org/library/papers/17159923PubMed
1316251342Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration.Antimicrob Agents Chemother2005https://conductscience.org/library/papers/16251342PubMed
1419433570Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria.Antimicrob Agents Chemother2009https://conductscience.org/library/papers/19433570PubMed
1518625681Polymyxins revisited.Clin Microbiol Rev2008https://conductscience.org/library/papers/18625681PubMed
1614585859Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis.J Antimicrob Chemother2003https://conductscience.org/library/papers/14585859PubMed
173139779Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model.J Infect Dis1988https://conductscience.org/library/papers/3139779PubMed
1811181360In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis.Antimicrob Agents Chemother2001https://conductscience.org/library/papers/11181360PubMed
1916447111Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America.Clin Infect Dis2006https://conductscience.org/library/papers/16447111PubMed
206181800Serum levels of acute phase and cardiac proteins after myocardial infarction, surgery, and infection.Br Heart J1982https://conductscience.org/library/papers/6181800PubMed

See all 28 referencesDownload CSV of references

Cited by83

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 161 citations.

PMIDTitleJournalYearIn PapersSource
42938753In Vitro and In Vivo Efficacy of the Broad-Spectrum β-Lactamase Inhibitor APC24-7 in Combination with Meropenem Against Carbapenem-Resistant Enterobacterales.Antibiotics (Basel)2026https://conductscience.org/library/papers/42938753PubMed
42921313Antimicrobial Peptides Beyond the Petri Dish: Translational Barriers to Therapeutic Development.ACS Bio Med Chem Au2026https://conductscience.org/library/papers/42921313PubMed
41787258Combination of 7-hydroxyflavone and colistin: antibacterial activity and mechanism against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.BMC Microbiol2026https://conductscience.org/library/papers/41787258PubMed
41746140Pharmacodynamic evaluation of BRII-693, a next-generation synthetic macrocyclic peptide antibiotic, in the neutropenic mouse thigh and lung infection models against gram-negative pathogens.Antimicrob Agents Chemother2026https://conductscience.org/library/papers/41746140PubMed
41405421Systematic review of antimicrobial pharmacokinetic/pharmacodynamic indices in murine thigh and hollow fibre dose fractionation studies analysed with a standard method.J Antimicrob Chemother2026https://conductscience.org/library/papers/41405421PubMed
41368010
Drug-resistant gram-negative bacterial infections in children in the Oceania region: review of the epidemiology, antimicrobial availability, treatment, clinical trial and pharmacokinetic data, and key evidence gaps.
Lancet Reg Health West Pac2025https://conductscience.org/library/papers/41368010PubMed
41222983Second-generation lysocins as therapeutics for treating Pseudomonas aeruginosa infections.Antimicrob Agents Chemother2025https://conductscience.org/library/papers/41222983PubMed
41053828Pseudomonas aeruginosa infection exacerbates elastase induced lung damage: characterisation of a novel murine two-hit model of pulmonary infection.Respir Res2025https://conductscience.org/library/papers/41053828PubMed
40547403Development of an LC-MS/MS method for quantification of colistin and colistin methanesulfonate in human plasma and its application to stability studies and therapeutic drug monitoring.J Mass Spectrom Adv Clin Lab2025https://conductscience.org/library/papers/40547403PubMed
40426512The α-Helical Amphipathic Peptide Alleviates Colistin-Induced Nephrotoxicity by Maintaining Mitochondrial Function in Both In Vitro and In Vivo Infection Models.Antibiotics (Basel)2025https://conductscience.org/library/papers/40426512PubMed
39066828Decoding the TAome and computational insights into parDE toxin-antitoxin systems in Pseudomonas aeruginosa.Arch Microbiol2024https://conductscience.org/library/papers/39066828PubMed
38998921Colistin: Lights and Shadows of an Older Antibiotic.Molecules2024https://conductscience.org/library/papers/38998921PubMed
38646595Dextrin conjugation to colistin inhibits its toxicity, cellular uptake and acute kidney injury in vivo.RSC Pharm2024https://conductscience.org/library/papers/38646595PubMed
37676873Development of an antibody fused with an antimicrobial peptide targeting Pseudomonas aeruginosa: A new approach to prevent and treat bacterial infections.PLoS Pathog2023https://conductscience.org/library/papers/37676873PubMed
37550398Targeted dosing for susceptible heteroresistant subpopulations may improve rational dosage regimen prediction for colistin in broiler chickens.Sci Rep2023https://conductscience.org/library/papers/37550398PubMed
37022170In Vivo Pharmacodynamic Profile of EVER206, a Novel Polymyxin Antimicrobial, against Gram-Negative Bacteria in the Murine Thigh Infection Model.Antimicrob Agents Chemother2023https://conductscience.org/library/papers/37022170PubMed
36751699
Chinese consensus guidelines for therapeutic drug monitoring of polymyxin B, endorsed by the Infection and Chemotherapy Committee of the Shanghai Medical Association and the Therapeutic Drug Monitoring Committee of the Chinese Pharmacological Society.
J Zhejiang Univ Sci B2023https://conductscience.org/library/papers/36751699PubMed
36718051Pharmacokinetic and pharmacodynamic properties of polymyxin B in Escherichia coli and Klebsiella pneumoniae murine infection models.J Antimicrob Chemother2023https://conductscience.org/library/papers/36718051PubMed
36588676Pharmacokinetics/pharmacodynamics of polymyxin B in patients with bloodstream infection caused by carbapenem-resistant Klebsiella pneumoniae.Front Pharmacol2022https://conductscience.org/library/papers/36588676PubMed
36558952Assessing Clinical Potential of Old Antibiotics against Severe Infections by Multi-Drug-Resistant Gram-Negative Bacteria Using In Silico Modelling.Pharmaceuticals (Basel)2022https://conductscience.org/library/papers/36558952PubMed

See all 83 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20028824

GET https://conductscience.org/api/papers/v1/20028824/references?page=2